Sep 11

Treatment of Knee Meniscus Pathology: Rehabilitation, Surgery, and Orthobiologics

Partial meniscectomy is performed more than any other orthopedic procedure in the United States. New research published by TOBI Alumni Faculty Dr. Gerard A. Malanga, MD, studies the use of orthobiologics such as platelet rich plasma and mesenchymal stem cells in augmenting surgical repairs or as stand-alone treatments, though research for use in meniscal tear management is limited. See the study here: Treatment of Knee Meniscus Pathology: Rehabilitation, Surgery, and Orthobiologics

Apr 11

TOBI Faculty Publications: March 2018

Below is a resource of all March 2018 regenerative medicine publications authored by TOBI Speakers and Faculty, including alumni faculty. Each month, we compile a list with links and brief summaries of all new research and studies to keep TOBI community members informed and on the cutting edge of regenerative medicine research. Studies are listed alphabetically by TOBI Faculty names. If you are a TOBI Faculty member or alumni and would like your publications included in the TOBI monthly publications...

Nov 6

TOBI Faculty Andrew Ittleman on the FDA’s Regulation of Stem Cells

TOBI 2017 Faculty Andrew Ittleman, JD, has published a valuable article on how the FDA should regulate human cells. This article, which appeared in The Regulatory Review, provides a brief history of the FDA's involvement in the regulation of human cells, starting with the Wall Street Journal Op-ed, "The FDA Wants to Regulate Your Cells", written by Scott Gottlieb in 2012. Gottlieb is now the Commissioner of the FDA. Ittleman analyzes Gottlieb's political history regarding the regulation of human cells,...